📣 VC round data is live. Check it out!

Medacta Group Valuation Multiples

Discover Medacta Group's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like iRhythm Holdings, Minimed Group, Lepu Medical Technology, Amplifon and more.

Medacta Group Overview

About Medacta Group

Medacta Group SA is involved in developing, manufacturing and distributing orthopedic and neurosurgical medical devices. The company offers solutions for Hip, Knee, Shoulder and Spine. The majority of the company's revenue is generated from Europe, Middle East, and Africa (EMEA) and the rest from other regions.


Founded

1999

HQ

Switzerland

Employees

1.9K

Financials (LTM)

Revenue: $829M
EBITDA: $233M

EV

$4B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Medacta Group Financials

Medacta Group reported last 12-month revenue of $829M and EBITDA of $233M.

In the same LTM period, Medacta Group generated $559M in gross profit, $233M in EBITDA, and $114M in net income.

Revenue (LTM)


Medacta Group P&L

In the most recent fiscal year, Medacta Group reported revenue of $796M and EBITDA of $229M.

Medacta Group is profitable as of last fiscal year, with gross margin of 67%, EBITDA margin of 29%, and net margin of 14%.

See analyst estimates for Medacta Group
LTMLast FY202320242025202620272028
Revenue$829M$796M$594M$687M$796M
Gross Profit$559M$534M$405M$465M$534M
Gross Margin67%67%68%68%67%
EBITDA$233M$229M$143M$187M$229M
EBITDA Margin28%29%24%27%29%
EBIT Margin17%17%15%15%16%
Net Profit$114M$111M$55M$85M$111M
Net Margin14%14%9%12%14%
Net Debt-$197M---

Financial data powered by Morningstar, Inc.

Medacta Group Stock Performance

Medacta Group has current market cap of $3B, and enterprise value of $4B.

Market Cap Evolution


Medacta Group's stock price is $174.01.

Medacta Group share price decreased by 5.1% in the last 30 days, and increased by 1.8% in the last year.

Medacta Group has an EPS (earnings per share) of $5.58.

See more trading valuation data for Medacta Group
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$4B$3B-1.3%-5.1%-9.1%1.8%$5.58

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Medacta Group Valuation Multiples

Medacta Group trades at 4.5x EV/Revenue multiple, and 16.0x EV/EBITDA.

See NTM and 2027E valuation multiples for Medacta Group

EV / Revenue (LTM)


Medacta Group Financial Valuation Multiples

As of June 3, 2026, Medacta Group has market cap of $3B and EV of $4B.

Medacta Group has a P/E ratio of 30.4x.

LTMLast FY202320242025202620272028
EV/Revenue4.5x4.7x6.3x5.4x4.7x
EV/EBITDA16.0x16.3x26.0x20.0x16.3x
EV/EBIT26.5x28.1x43.0x35.3x28.8x
EV/Gross Profit6.7x7.0x9.2x8.0x7.0x
P/E30.4x31.2x62.9x40.9x31.2x
EV/FCF143.7x158.4xn/mn/mn/m

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Medacta Group Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Medacta Group Margins & Growth Rates

Medacta Group grew revenue by 12% and EBITDA by 10% in the last fiscal year.

In the most recent fiscal year, Medacta Group reported gross margin of 67%, EBITDA margin of 29%, and net margin of 14%.

See estimated margins and future growth rates for Medacta Group

Medacta Group Margins

Last FY202420252026202720282029
Gross Margin67%68%67%68%
EBITDA Margin29%27%29%28%
EBIT Margin17%15%16%17%
Net Margin14%12%14%14%
FCF Margin3%0%1%3%

Medacta Group Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth12%16%16%12%
Gross Profit Growth14%15%15%14%
EBITDA Growth10%30%22%10%
EBIT Growth14%22%23%17%
Net Profit Growth9%54%31%9%
FCF Growth24%(135%)290%163%

Data powered by FactSet, Inc. and Morningstar, Inc.

Medacta Group Operational KPIs

Medacta Group's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.2M for the same period.

Medacta Group's Rule of 40 is 40% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Medacta Group's Rule of X is 59% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Medacta Group
LTMLast FY202320242025202620272028
Rule of 4042%40%---
Bessemer Rule of X62%59%---
Revenue per Employee-$0.4M---
Opex per Employee-$0.2M---
S&M Expenses to Revenue34%34%37%36%34%
G&A Expenses to Revenue13%13%4%4%4%
R&D Expenses to Revenue3%3%4%4%3%
Opex to Revenue-51%54%52%51%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Medacta Group Competitors

Medacta Group competitors include iRhythm Holdings, Minimed Group, Lepu Medical Technology, Amplifon, Merit Medical Systems, ICU Medical, Envista Holdings, Integer Holdings, MGI Tech and Haemonetics.

Most Medacta Group public comparables operate across Medical Devices, DeepTech and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
iRhythm Holdings4.9x4.5x52.9x42.3x
Minimed Group1.3x1.1x32.3x10.3x
Lepu Medical Technology3.8x3.7x12.2x12.2x
Amplifon1.8x1.8x8.2x8.0x
Merit Medical Systems2.6x2.5x10.4x10.2x
ICU Medical1.9x2.0x10.6x10.5x
Envista Holdings1.6x1.5x11.4x11.0x
Integer Holdings2.4x2.4x11.0x11.3x

This data is available for Pro users. Sign up to see all Medacta Group competitors and their valuation data.

Start Free Trial

Acquisitions by Medacta Group

Medacta Group has acquired 1 company to date.

Last acquisition by Medacta Group was on February 9th 2017. Medacta Group acquired Vivamed for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by Medacta Group

Vivamed
Description
-
HQ CountryAustria
HQ City
-
Deal Date9 Feb 2017
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Medacta Group acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Medacta Group

When was Medacta Group founded?Medacta Group was founded in 1999.
Where is Medacta Group headquartered?Medacta Group is headquartered in Switzerland.
How many employees does Medacta Group have?As of today, Medacta Group has over 1K employees.
Is Medacta Group publicly listed?Yes, Medacta Group is a public company listed on SIX Swiss Exchange.
What is the stock symbol of Medacta Group?Medacta Group trades under MOVE ticker.
When did Medacta Group go public?Medacta Group went public in 2019.
Who are competitors of Medacta Group?Medacta Group main competitors include iRhythm Holdings, Minimed Group, Lepu Medical Technology, Amplifon, Merit Medical Systems, ICU Medical, Envista Holdings, Integer Holdings, MGI Tech, Haemonetics.
What is the current market cap of Medacta Group?Medacta Group's current market cap is $3B.
What is the current revenue of Medacta Group?Medacta Group's last 12 months revenue is $829M.
What is the current revenue growth of Medacta Group?Medacta Group revenue growth (NTM/LTM) is 13%.
What is the current EV/Revenue multiple of Medacta Group?Current revenue multiple of Medacta Group is 4.5x.
What is the current EBITDA of Medacta Group?Medacta Group's last 12 months EBITDA is $233M.
What is Medacta Group's EBITDA margin?Medacta Group's last 12 months EBITDA margin is 28%.
What is the current EV/EBITDA multiple of Medacta Group?Current EBITDA multiple of Medacta Group is 16.0x.
What is the current FCF of Medacta Group?Medacta Group's last 12 months FCF is $26M.
What is Medacta Group's FCF margin?Medacta Group's last 12 months FCF margin is 3%.
What is the current EV/FCF multiple of Medacta Group?Current FCF multiple of Medacta Group is 143.7x.
How many companies Medacta Group has acquired to date?As of June 2026, Medacta Group has acquired 1 company.
What was the largest acquisition by Medacta Group?None of the M&A deals Medacta Group has completed have disclosed valuations.
What companies Medacta Group acquired?Medacta Group acquired Vivamed.
In how many companies Medacta Group has invested to date?Medacta Group hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Medacta Group

Lists including Medacta Group

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial